Human Disease Treatment Articles & Analysis
5 news found
Her experience also includes nine years with GlaxoSmithKline (GSK) in senior medical leadership roles including, Vice President of Medical Excellence and Quality, Vice President and Global Head, Infectious Diseases Medicines Development Center, as well as Vice President of Stiefel Laboratories, GSK's dermatology franchise focusing on acne treatments and ...
The program will begin with a clinical study into the treatment of carotid artery disease using R-One™, the first robotic platform developed by Robocath, which has been on the market since 2019. This first-generation robotic solution was designed to improve the treatment of cardiovascular disease by enhancing ...
ByRobocath
The microbial community helps to improve diagnosis, detect and treat diseases early, and reduce the risk of diseases. The use of next-generation sequencing technology to identify microbial communities (including all microbes and all their genetic elements that exist on our body surfaces and bodies) allows us to now incorporate this important ...
“Now we see a wealth of plasma-derived and non-plasma therapeutic candidates identified by Alkahest that can significantly support the unmet needs of many diseases associated with aging.” Karoly Nikolich, CEO of Alkahest, said, “We are excited to join forces with Grifols, an industry leader in plasma-derived medicines, to realize our shared vision and mission ...
Jackson Laboratory President and CEO Richard Woychik, Ph.D., announced today that he will leave the institution in January 2011 to accept a new position as deputy director of the National Institute of Environmental Health Sciences (NIEHS) in Research Triangle Park, N.C. “It has been a great honor to serve The Jackson Laboratory," Woychik said. "I will miss the many fine people who have ...